Artimmune SAS
keyboard_backspaceBack to Home
Contact
13 avenue Buffon
45100 Orléans
France
Directrice d'études précliniques
About us
Artimmune is a preclinical research company in immunology. The company offers in vitro and animal models of human inflammatory pathologies, to demonstrate the therapeutic efficacy of drug candidates. Artimmune is highly specialized in the study of inflammatory diseases of the lungs, gut and skin, but also neuroinflammatory disorders such as multiple sclerosis.
Key-words: fibrosis, allergic asthma, COPD, sepsis, IBD, multiple sclerosis, atopic dermatitis, psoriasis, infection
Business offer
Artimmune is your scientific partner specializing in drug discovery for inflammation and infection. Our services encompass preclinical research, immunology, and inflammation research, with a focus on lung diseases. We excel in preclinical investigations of lung functions, including plethysmography, bronchoalveolar lavage, cytology, histology, immunohistochemistry, and analysis of biochemical, immunological, and molecular parameters. Our mission is to evaluate novel drug candidates in lung, skin, and gut diseases, but also neuroinflammatory pathologies like multiple sclerosis. Our catalogue is constently improving and is available on our website.
Activities
- Service
- Immunology
- Inflammation
- Target selection & validation
- Assay development in in-vitro & in-vivo models
- Preclinical biomarkers
- Research exploratory Companion biomarkers
- Animal biomarkers
- Predictive biomarkers
- Treatment efficacy
- Disease progression / follow-up
- Companion biomarkers
- Treatment efficacy
- Treatment monitoring
- Target cell isolation
- Differentiated Cell
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Target Identification
- Assay development in in-vitro & in-vivo models
- Research exploratory companion biomarkers
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Antigen identification, selection, optimization, and validation
- Assay development with in-vitro & in-vivo models
- Pathogen-host knowledge
- In-vitro and in-vivo models
- Antigen-protective immune-response profile
- Humoral response characterization:
- Antibody dosage
- Other serological assays
- Cell mediated immunity response
- Research exploratory biomarkers
- efficiency vaccination
- protection correlation
- Challenge test – Gold Standard
- In-vivo animal models
- Induced immune response characterization
- Ex-vivo models
- Vaccine delivery/Administration routes
- Route of Administration
- Intramuscular route
- intradermal route
- Nasal route
- Mucosal routes
